RTKN

RTKN (Rhotekin) functions as a growth-promoting effector that drives proliferation and suppresses apoptosis across multiple cell contexts, behaving as an oncogene in hepatocellular carcinoma where its overexpression promotes proliferation and blocks apoptosis while its silencing imposes G2/M arrest through NF-κB signaling (PMID:27922690). A recurrent theme is post-transcriptional repression of RTKN by microRNAs that bind its 3'UTR: miR-145 represses RTKN to limit breast cancer cell growth (PMID:19360360), let-7a downregulates RTKN to restrain colon cancer growth and metastasis, with RTKN re-expression rescuing this inhibition (PMID:27498032), and miR-152 targets the RTKN 3'UTR to reverse RTKN-driven HCC growth (PMID:27922690). In kidney ischemia-reperfusion injury, RTKN is de-repressed when the lncRNA MEG3 sequesters miR-145-5p, and the resulting RTKN upregulation activates Wnt/β-catenin signaling to promote mitophagy and apoptosis (PMID:33602903). Beyond these miRNA-regulated proliferative and survival roles, the direct molecular activity, structure, and physical effectors of RTKN have not been characterized in the available corpus.

1. 2009 Medium

   Establishing that RTKN is a direct target of a growth-suppressive microRNA connected its expression level to a proliferative phenotype.

   Evidence Luciferase 3'UTR reporter, siRNA knockdown, Western blot and RT-PCR in MCF-7 breast cancer cells

   PMID:19360360

   Open questions at the time

   • molecular activity of RTKN downstream of miR-145 not defined
   • no direct binding partners or effectors identified
   • single cell line and single lab
2. 2016 Medium

   Gain- and loss-of-function defined RTKN as an oncogene acting through NF-κB and cell-cycle control, and identified a second repressive microRNA.

   Evidence Overexpression/knockdown in HepG2/Hep3B cells, flow cytometry for apoptosis and cell cycle, miR-152 3'UTR reporter assay

   PMID:27922690

   Open questions at the time

   • mechanism linking RTKN to NF-κB activation not resolved
   • no biochemical demonstration of how RTKN engages the pathway
3. 2016 Medium

   A rescue experiment placed RTKN epistatically downstream of let-7a, showing RTKN is the functionally relevant target driving growth and metastasis.

   Evidence let-7a mimic transfection with RTKN re-introduction, growth and metastasis assays in HCT-116 and SW620 colon cancer cells

   PMID:27498032

   Open questions at the time

   • metastasis-promoting mechanism of RTKN not defined
   • downstream signaling in colon cancer not mapped
4. 2021 Medium

   Embedding RTKN in a MEG3/miR-145-5p axis showed it activates Wnt/β-catenin signaling to drive mitophagy and apoptosis in a non-cancer injury context.

   Evidence RNA pulldown and reporter assays, siRNA knockdown, Wnt/β-catenin pathway readouts, in vivo kidney ischemia-reperfusion mouse model in HK-2 cells

   PMID:33602903

   Open questions at the time

   • direct mechanism by which RTKN activates Wnt/β-catenin not established
   • molecular link to mitophagy machinery unknown

• The intrinsic molecular activity of RTKN and its direct protein partners remain undefined in this corpus, leaving open how it transduces signals to NF-κB and Wnt/β-catenin.
• no biochemical activity or direct binding partners characterized
• no structural data
• context-dependence (oncogenic vs injury-promoting) not mechanistically reconciled